How Continuous Manufacturing is Advancing Bio/Pharma Production: Continuous manufacturing offers advantages in both biotherapeutic and API manufacturing but still poses challenges.
| Publicado en: | Pharmaceutical Technology Europe Vol. 37; no. 2; pp. 16 - 22 |
|---|---|
| Autor principal: | |
| Formato: | pictorial Journal Article |
| Publicado: |
MJH Life Sciences
Mar2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=191547996&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 191547996 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 17537967 5NG jtl: Pharmaceutical Technology Europe issn: 17537967 maglogo: N pubinfo: dt: Mar2025 vid: 37 iid: 2 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 191547996 191547996 191547996 191547996 ppf: 16 ppct: 6 formats: fmt: @attributes: type: P tig: atl: How Continuous Manufacturing is Advancing Bio/Pharma Production: Continuous manufacturing offers advantages in both biotherapeutic and API manufacturing but still poses challenges. aug: au: MIRASOL, FELIZA sug: subj: Pharmaceutical Companies Manufacturing Industry Biological Products RNA RNA, Messenger United States Food and Drug Administration COVID-19 Pandemic Dosage Forms pubtype: Trade Publication doctype: pictorial Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|